Related Experiment Video
Updated: Jan 25, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeting ATG4 in Cancer Therapy
Yuanyuan Fu1, Zhiying Huang2, Liang Hong3
1School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China. fuyy6@mail2.sysu.edu.cn.
Abstract:
Autophagy is a lysosome-mediated degradation pathway that enables the degradation and recycling of cytoplasmic components to sustain metabolic homoeostasis. Recently, autophagy has been reported to have an astonishing number of connections to cancer, as tumor cells require proficient autophagy in response to metabolic and therapeutic stresses to sustain cell proliferation. Autophagy-related gene 4 (ATG4) is essential for autophagy by affecting autophagosome formation through processing full-length microtubule-associated protein 1A/1B-light chain 3 (pro-LC3) and lipidated LC3. An increasing amount of evidence suggests that ATG4B expression is elevated in certain types of cancer, implying that ATG4B is a potential anticancer target. In this review, we address the central roles of ATG4B in the autophagy machinery and in targeted cancer therapy. Specifically, we discuss how pharmacologically inhibiting ATG4B can benefit cancer therapies.
Insights
Autophagy, a cellular recycling process, is crucial for cancer cell survival. Inhibiting Autophagy-related gene 4B (ATG4B) shows promise as a targeted cancer therapy strategy.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Autophagy is a vital cellular degradation and recycling pathway essential for maintaining metabolic balance.
- Cancer cells exploit autophagy to survive metabolic and therapeutic stresses, promoting proliferation.
- Autophagy-related gene 4 (ATG4) proteins, particularly ATG4B, are critical for autophagosome formation via LC3 processing.
Purpose of the Study:
- To review the role of ATG4B in autophagy.
- To explore ATG4B's significance in cancer.
- To discuss the therapeutic potential of ATG4B inhibition in cancer treatment.
Main Methods:
- Literature review of autophagy mechanisms.
- Analysis of ATG4B expression in various cancers.
- Examination of studies on ATG4B inhibition and cancer therapy.
Main Results:
- ATG4B expression is elevated in several cancer types, indicating its oncogenic role.
- ATG4B is essential for the autophagy process, specifically LC3 lipidation.
- Pharmacological inhibition of ATG4B presents a potential strategy to target cancer cells.
Conclusions:
- ATG4B plays a central role in both the autophagy pathway and cancer progression.
- Targeting ATG4B offers a promising avenue for developing novel anticancer therapies.
- Inhibiting ATG4B may enhance the efficacy of existing cancer treatments by disrupting tumor cell survival mechanisms.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Group Therapy
Psychodynamic Therapy
Humanistic Therapy

